Omar Jawdat

University of Kansas Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (5)

Zachary Simmons

UNITED STATES

View details

Heather Wilkins

Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

Swathy Chandrashekhar

University of California, San Francisco

UNITED STATES

View details

Tiffany Schwasinger-Schmidt

Assistant Professor of Medicine

UNIVERSITY OF KANSAS SCHOOL OF MEDICINE

UNITED STATES

View details

Jeffrey Statland

Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Omar Jawdat

Research Interests

Explore related searches

Contact this professor

Articles (10)

CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial

Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial

Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial

Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial

Outcomes after intervention for enteral nutrition in patients with amyotrophic lateral sclerosis in multidisciplinary clinics

A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.

Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study

Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial

Collaborators (5)

Zachary Simmons

Heather Wilkins

Swathy Chandrashekhar

Tiffany Schwasinger-Schmidt

Jeffrey Statland

Make your next move.